Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel

Journal of the Chinese Medical Association

Volumn 76, Issue 1, 2013, Pages 9-14

  Huang, Kuang Wei ^a,b   Luo, Jiing Chyuan ^a,b   Leu, Hsin Bang ^a,b   Huang, Chin Chou ^a,b   Hou, Ming Chih ^a,b   Chen, Tseng Shing ^a,b   Lu, Ching Liang ^a,b   Lin, Han Chieh ^a,b   Lee, Fa Yauh ^a,b   Chang, Full Young ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute coronary syndrome; Aspirin; Clopidogrel; Mechanical ventilation; Upper GI bleeding

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PROTON PUMP INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PEPTIC ULCER; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; UPPER GASTROINTESTINAL BLEEDING;

AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY ARTERY DISEASE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; UPPER GASTROINTESTINAL TRACT;

EID: 84872408157     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2012.09.004     Document Type: Article

References (22)

1. Mehta S.R., Yusuf S. Clopidogrel in unstable angina to prevent recurrent events (CURE) study investigators: the clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme; Rationale, design, and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000, 21:2033-2041.
2. Steinhubl S.R., Berger P.B., Mann J.T., Fry E.T., DeLago A., Wilmer C., et al. Clopidogrel for the reduction of events during observation. J Am Med Assoc 2002, 288:2411-2420.
3. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E., et al. American Heart Association Task Force on Practice Guidelines; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007, 116:e.148-e.304.
4. Kushner F.G., Hand M., Smith S.C., King S.B., Anderson J.L., Antman E.M., et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009, 54:2205-2241.
5. Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004, 364:331-337.
6. Luo J.C. Gastro-protective strategy in aspirin users. J Chin Med Assoc 2009, 72:343-345.
7. Ng F.H., Lam K.F., Wong S.Y., Chang C.M., Lau Y.K., Yuen W.C., et al. Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy. Digestion 2008, 77:173-177.
8. Cook D.J., Fuller H.D., Guyatt G.H., Chang C.M., Lau Y.K., Yuen W.C., et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994, 330:377-381.
9. Sesler J.M. Stress-related mucosal disease in the intensive care unit. AACN Adv Crit Care. 2007, 18:119-126.
10. Ng F.H., Wong S.Y., Lam K.F., Chang C.M., Lau Y.K., Chu W.M., et al. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome. Am J Gastroenterol 2008, 103:865-871.
11. Keller T.T., Squizzato A., Middeldorp S. Clopidegrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Sys Rev 2007, (3):CD005158.
12. Luo J.C., Chang F.Y., Lin H.Y., Lu R.H., Lu C.L., Chen C.Y., et al. The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment. Aliment Pharmacol Ther 2002, 16:1241-1248.
13. Luo J.C., Huang K.W., Leu H.B., Chen L.C., Hou M.C., Li C.P., et al. Randomized clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer. Aliment Pharmacol Ther 2011, 34:519-525.
14. Chan F.K., Chung S.C., Suen B.Y., Lee Y.T., Leung W.K., Leung V.K., et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter infection who are taking low-dose aspirin or naproxen. New Engl J Med 2001, 344:967-973.
15. Ng F.H., Tunggal P., Chu W.M., Lam K.F., Li A., Chan K., et al. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. Am J Gastroenterol 2012, 107:389-396.
16. Hsiang K.W., Chen T.S., Lin H.Y., Luo J.C., Lu C.L., Lin H.C., et al. Incidence and possible risk factors for clinical upper GI events in patients administrating selective cyclooxygenase-2 inhibitors: a prospective, observational, cohort study in Taiwan. Clin Ther 2010, 32:1294-1303.
17. Chin M.W., Yong G., Bulsara M.K., Rankin J., Forbes G.M. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol 2007, 102:2411-2416.
18. Luo J.C., Leu H.B., Huang K.W., Huang C.C., Hou M.C., Lin H.C., et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011, 83:E1345-E1351.
19. Huang K.W., Luo J.C., Leu H.B., Lin H.C., Lee F.Y., Chan W.L., et al. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study. Aliment Pharmacol Ther 2012, 35:796-802.
20. Luk H.H. Use of gastroprotective drugs in patients receiving low-dose aspirin. J Chin Med Assoc 2009, 72:356-361.
21. Yeomans N.D., Lanas A.I., Talley N.J., Thomson A.B., Daneshjoo R., Eriksson B., et al. Prevalence and incidence of gastroduodenal ulcers during treatment of vascular protective dose of aspirin. Aliment Pharmacol Ther 2005, 22:795-801.
22. Hung H.H., Chen T.S., Lin H.C. Immunoglobulin G antibody against Helicobacter pylori is an accurate test for atrophic gastritis. J Chin Med Assoc 2010, 73:355-359.